Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using in vivo microscopy, red blood cell (RBC) velocities, functional capillary density (FCD), and overall changes in capillary blood flow (PI) were estimated following intraductal infusion of sodium taurocholate (0.8 ml; 4%) alone or in combination with systemic administration of somstostatin (single bolus
SMS
100 microg/100 g body wt). Sodium taurocholate mediated a significant transient decrease in RBC velocities and a sustained decrease in FCD, which were paralleled by dramatic flow heterogeneity. Therefore, a significant reduction in overall capillary blood flow was calculated. Additional
SMS
treatment reduced microcirculatory impairment as expressed by reduction of blood flow heterogeneity, a less rarified functional capillary density, and a recovery of RBC velocities and acinar capillary overall perfusion to control values. As a result of this microcirculatory improvement, pancreas histology revealed slightly less severe tissue damage compared to the non-
SMS
-treated
pancreatitis
group. These findings demonstrate that exogenous
SMS
infusion can improve microcirculatory failure in acute biliary
pancreatitis
, which should have a beneficial effect on the course of the disease.
...
PMID:Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis. 953 54
We studied the effects of SMS201-995, a long-acting somatostatin analogue, on bile-induced acute pancreatitis in the dog. According to morphometrical study, parenchymal necrotic ratio, zymogen granules area and zymogen granules occupied ratio of acinus were significantly decreased in
SMS
-treated
pancreatitis
. These results suggests that
SMS
-treated
pancreatitis
showed less damage than non-treated ones and decreased secretion of pancreatic enzyme. On the other hand, pancreatic blood flow showed a stronger decrease in
SMS
-treated dogs than in non-treated ones, and a significant difference was observed at 15 minutes and 1 hour after induction of
pancreatitis
. Many clinical and experimental evidences suggest that pancreatic ischemia causes acute pancreatitis.
Pancreatitis
may be worsened by an early phase treatment with SMS201-995, because this substance reduces pancreatic tissue blood flow. The harmful effect of this substance on pancreatic tissue blood flow must be kept in mind when SMS201-995 is used for therapeutic purpose of acute pancreatitis.
...
PMID:[Experimental study on the therapeutic effects of SMS201-995 on bile-induced acute pancreatitis in the dog]. 954 45
<< Previous
1
2